Nuveen’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-926,327
Closed -$25M 3360
2024
Q2
$25M Buy
926,327
+530,091
+134% +$11M 0.01% 985
2024
Q1
$7.26M Buy
396,236
+279,360
+239% +$4.43M ﹤0.01% 1785
2023
Q4
$1.43M Buy
116,876
+1,726
+1% +$16.2K ﹤0.01% 2571
2023
Q3
$1.73M Sell
115,150
-99,601
-46% -$2.07M ﹤0.01% 2357
2023
Q2
$6.98M Sell
214,751
-3,877
-2% -$142K ﹤0.01% 1729
2023
Q1
$8.55M Buy
218,628
+43,825
+25% +$2.14M ﹤0.01% 1584
2022
Q4
$9.24M Buy
174,803
+75,911
+77% +$3.7M ﹤0.01% 1547
2022
Q3
$4.45M Sell
98,892
-2,385
-2% -$103K ﹤0.01% 1974
2022
Q2
$3.69M Sell
101,277
-1,599
-2% -$58.1K ﹤0.01% 2139
2022
Q1
$3.95M Buy
102,876
+1,258
+1% +$44.3K ﹤0.01% 2180
2021
Q4
$3.95M Sell
101,618
-31,670
-24% -$1.58M ﹤0.01% 2248
2021
Q3
$7.76M Sell
133,288
-21,354
-14% -$1.12M ﹤0.01% 1963
2021
Q2
$7.4M Buy
154,642
+17,159
+12% +$874K ﹤0.01% 2046
2021
Q1
$6.96M Sell
137,483
-2,206
-2% -$123K ﹤0.01% 1993
2020
Q4
$8.8M Sell
139,689
-36,761
-21% -$2.28M ﹤0.01% 1791
2020
Q3
$11.9M Sell
176,450
-34,081
-16% -$1.86M ﹤0.01% 1412
2020
Q2
$8.82M Buy
210,531
+17,502
+9% +$672K ﹤0.01% 1560
2020
Q1
$6.08M Sell
193,029
-28,633
-13% -$1.15M ﹤0.01% 1594
2019
Q4
$8.95M Buy
221,662
+111,906
+102% +$3.92M ﹤0.01% 1652
2019
Q3
$3.57M Sell
109,756
-6,920
-6% -$276K ﹤0.01% 2134
2019
Q2
$5.65M Buy
+116,676
New +$4.96M ﹤0.01% 1915

Other funds holding SILK

Nuveen's SILK Position: Q3 2024 in Review

Nuveen sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2024, closing a stake of 926,327 shares — an estimated $25M sold.

Nuveen first reported a position in SILK in Q2 2019 and held it in 21 quarters. The position peaked at $25M in Q2 2024. 1 fund tracked by Wall St. Rank holds SILK as of Q3 2024.

  • Nuveen reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Nuveen sold 926,327 Silk Road Medical, Inc. Common Stock shares in Q3 2024, an estimated $25M.
  • Nuveen first reported a position in Silk Road Medical, Inc. Common Stock in Q2 2019 and held it in 21 quarters.
  • Nuveen's Silk Road Medical, Inc. Common Stock position peaked at $25M in Q2 2024.
  • 1 fund tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2024.

Based on Nuveen's 13F filing for Q3 2024, filed 14 Nov 2024.